cDNA microarray gene expression analysis and toxicological phenotype for anticancer drug

Journal of Veterinary Medical Science

Volumn 66, Issue 11, 2004, Pages 1339-1345

  Lee, Gyoung Jae ^a   Lee, Wan Seon ^b   Jeon, Ki Seon ^b   Um, Chan Hwi ^b   Kim, Yang Suk ^b,c   Kim, Seung Jun ^d   Lee, Chang Hyeon ^d   Yoon, Hyun Kyu ^d   Hwang, Seung Yong ^d   Park, Joon Suk ^e   Hwang, Jae Woong ^e   Kang, Kyung Sun ^e   Lee, Yong Soon ^e   Kim, Maeng Sup ^f   Chon, Kum Jin ^a   Yeo, Chan Dong ^a   Kang, Jong Soo ^a  

^a Research Institute   (South Korea)

^b ISTECH Inc   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

^d Hanyang University   (South Korea)

^e Seoul National University   (South Korea)

^f Hanmi Pharmaceutical Co Ltd   (South Korea)

Author keywords

Anti cancer agent; cDNA microarray; Orally absorbable paclitaxol; Paclitaxel; Toxicogenomics

Indexed keywords

ANTINEOPLASTIC AGENT; PACLITAXEL;

ANIMAL; ARTICLE; COMPARATIVE STUDY; DNA MICROARRAY; DRUG EFFECT; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; METHODOLOGY; ORAL DRUG ADMINISTRATION; PHENOTYPE; RAT; SEX DIFFERENCE; SPRAGUE DAWLEY RAT; TOXICOGENETICS;

ADMINISTRATION, ORAL; ANIMALS; ANTINEOPLASTIC AGENTS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INJECTIONS, INTRAPERITONEAL; MALE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PACLITAXEL; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; SEX FACTORS; TOXICOGENETICS;

EID: 16644380597     PISSN: 09167250     EISSN: None     Source Type: Journal    
DOI: 10.1292/jvms.66.1339     Document Type: Article

References (38)

1. Aboushadi, N., Enfelt, W.H, Paton, V.G. and Krisans, S.K. 1999. Role of peroxisomes in isoprenoid biosynthesis. J. Histochem. Cytochem. 47: 1127-1132.
2. Bristol-Myers Squibb Co. 2000. Taxol Injection Information.
3. Chien, E.K. and Macgregor, C. 2003. Expression and regulation of the rat prostaglandin E2 receptor type 4 (EP4) in pregnant cervical tissue. Am. J. Obstet. Gynecol. 189: 1501-1510.
4. Dai, Z., Kerzic, P., Schroeder, W.G. and McNiece, I.K. 2001. Deletion of Src homology 3 domain and C-terminal proline-rich sequences in Bcr-Abi prevents Abi interactor 2 degradation and spontaneous cell migration and impairs leukemogenesis. J. Biol Chem. 276: 28954-28960.
5. Danielova, I.G., Holubova, J., Soucek, P. and Kluckova, H. 2000. Cytotoxicity of cyclophosphamide, pacliaxel and docetaxel for tumor cell line in vitro: effects of concentration, time and cytochrome P450-catalyzed metabolism. Arch. Toxicol. 74: 437-446.
6. Dettling, M. and Buhlmann, P. 2003. Boosting for tumor classification with gene expression data. Bioinformatics 19: 1061-1069.
7. Dudoit, S. and Fridlyand, J. 2003. A prediction-based resampling method for estimating the number of clusters in a dataset. Genome Biol. 3: 25.
8. Emile, F., Nuwaysir, M., Bitnner, J., Trent, J., Carl, B. and Cynthia, A.A. 1999. Microarrays and Toxicology: The advent of Toxicogenomics. Mol. Carcino. 24: 153-159.
9. Eisen, M.B., Spellman, P.T., Brown, P.O. and Botstein, D. 1998. Clustering analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U.S.A. 95: 14863-14868.
10. Erdemir, T., Bilican, B., Oncel, D., Coding, C.R. and Yavuzer, U. 2002. DNA damage-dependent Interaction of the nuclear matrix protein C1D with Translin-associated factor T (TRAX). J. Cell. Sci. 1: 207-216.
11. Faheez, M., Marchettini, P., Stuart, O.A. and Sugarbaker, P.H. 2003. Pharmacokinetics and tissue distribution of intraperitoneal paclitaxel with different carrier solution. Cancer Chem. Pharmacol. 5: 405-410.
12. Fromaget, M., Vercherat, C., Zhang, C.X., Zablewska, B., Gaudray, P., Chayvialle, J.A., Calender, A. and Cordier-Bussat, M. 2003. Functional characterization of a promoter region in human MEN1 tumor suppression gene. J. Mol. Biol. 10: 87-102.
13. Gary, E.M. 2002. Toxicogenomics and toxic torts. Trends in Biotech. 20: 329-332.
14. Gelb, B.D., Shi, G.P., Heller, M., Weremowicz, S., Morton, C., Desnick, R.J. and Chapman, H.A. 1997. Structure and chromosomal assignment of the human cathepsin K gene. Genomics 41: 258-262.
15. Gueritte-Voegelein, F., Guenard, D., Lavelle, F., Le Goff, M.T., Mangatal, L. and Potier, P. 1991. Relationships between the structure of taxol analogues and their antimitotic activity. J. Med. Chem. 34: 992-998.
16. Hamadeh, H.K., Bushel, P.R., Jayadev, S., Martin, K., DiSorbo, O., Sieber, S., Bennett, L., Tennant, R., Stoll, R., Barrett, J.C., Blanchard, K., Paules, R. and Afshari, C.A. 2002. Gene Expression analysis reveals chemical-specific profiles. Toxicological Sci. 27: 219-231.
17. Hanley, P.J., Gopalan, K.V., Lareau, R.A., Srivastava, D.K., von Meltzer, M. and Daut, J. 2003. Beta-oxidation of 5-hydroxydecanoate, a putative block of mitochondrial ATP-sensitive potassium channels. J. Physiol. 1: 387-392.
18. Holmes, F.A., Walters, R.S., Theriault, R.L., Forman, A.D., Newton, L.K., Raber, M.N., Buzdar, A.U., Frye, D.K. and Hortobagyi, G.N. 1991. Phase II trial of taxol, an active drug in the treatment of metastatic breast cancer. J. Natl. Cancer Inst. 18; 83: 1797-1805.
19. Iwata, J. and Yamamoto, K. 2003. Involvement of cathepsin D and cathepsin E in inhibition of tumor growth and metastasis through the production of angiogenetic inhibitors. Tanpakushltsu Kakusan Koso 48: 1928-1933.
20. Jansen, G.A., Verhoeven, N.M., Denis, S., Romeijin, G., Jakobs, C., ten Brink, H.J. and Wanders, R.J. 1999. Phytonic acid alpha-oxidation: Identification of 2-hydroxyphytanoyl-CoA lyase in rat liver and its location in peroxisomes. Biochem. Biophy Acta. 1440: 176-182.
21. Kao, L.C., Germeyer, A., Tulac, S., Lobo, S., Yang, J.P., Taylor, R.N., Osteen, K., Lessey, B.A. and Giudice, L.C. 2003. Expression profiling of endometrium from women with endometriosis reveals candidate genes for disease-based implantation failure and infertility. Endocrinology 144: 2870-2881.
22. Kawamura, K., Kobayashi, T., Matsuno, K. and Ishiwata, K. 2003. Different brain kinetics of two sigma 1 receptor ligands, [3H](+)-pentazocine and [11C]SA4503, by P-glycoprotein modulation. Synapse 48: 80-86.
23. Kostyukova, A., Maeda, K., Yamauchi, E., Krieger, I. and Maeda, Y. 2000. Domain structure of tropomodulin: distinct properties of the N-terminal and C-terminal halves. Eur J Biochem. 267: 6470-6475.
24. Kumar, N. 1981. Taxol-induced polymerization of purified tubulin. J. Biol. Chem. 256: 10435-10441.
25. Marilyn, J.A. and MacGregor, J.T. 2002. Toxicology and genetic toxicology in the new era of "Toxicogenomics": impact of "-omics" technologies. Mutat. Res. 499: 13-25.
26. McGuire, W.P., Rowinsky, EK., Rosenshein, N.B., Grumbine, F.C., Ettinger, D.S., Armstrong, D.K. and Donehower, R.C. 1989. Taxol: a unique antineoplastic agent with significant activity in advanced ovarian epithelial neoplasms. Ann Intern Med. 111: 273-279.
27. Nair, R.R., Rodgers, J.R. and Schwarz, L.A. 2002. Enhancement of trangene expression by combining glucocorticoids and anti-mitotic agents during transient transfection using DNA-cation Liposomes. Mol. Ther. 5: 455-462.
28. Ni, W., Egashira, K., Kataoka, C., Kitamoto, S., Koyanagi, M., Inoue, S. and Takeshita, A. 2001. Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis. Circ Res. 89: 415-421.
29. Nwaozuzu, O.M., Sellers, L.A. and Barrand, M.A. 2003. Signalling pathways influencing basal and H(2)O(2)-induced P-glycoprotein expression in endothelial cells derived from the blood-brain barrier. J. Neurochem. 87: 1043-1051.
30. Park, P.J., Pagano, M. and Bonetti, M. 2001. A nonparametric scoring algorithm for identifying informative genes from microarray data. Pac. Symp. Biocomput. 6: 52-63.
31. Shi, X., Shi, W., Li, Q., Song, B., Wan, M., Bai, S. and Cao, X. 2003. A glucocorticoid-induced leucine-zipper protein, GILZ, inhibits adipogenesis of mesenchymal cells. EMBO Rep. 4: 374-380.
32. Sinz, A., Bantscheff, M., Mikkat, S., Ringel, B., Drynda, S., Kekow, J., Thiesen, H.J. and Glocker, M.O. 2002. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis. 23: 3445-3456.
33. Sophie, C., Ilaria, C., Joerg, H., Kathie, W.-C. and Stefano, F. 1999. PCTAIRE-1: Characterization, subcellular distribution, and cell cycle-dependent kinase activity. Cell Growth Differentiation 10: 611-620.
34. Steven, J., Bulera, S. M., Eddy, E., Ferguson, T. A., Jatkoe, J. F., Reindel, M. R., Bleavins, and Felix, A., De La Iglesia, 2001. RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarrays. Hepatology 33: 1239-1258.
35. Wang, T. H., Popp, D. H., Wang, H. S., Saitoh, M., Mural, J. G., Henley, D. C., Ichijo, H. and Wimalasena, J. 1999. Microtubule dysfunction induced by paclitaxel initiates apoptosis through both c-Jun N-terminal kinase (JNK)-dependent and - independent pathways in ovarian cancer cells. J. Biol. Chem. 274: 8208-8216.
36. Westerbacka, J., Yki-Jarvinen, H., Vehkavaara, S., Hakkinen, A.M., Andrew, R., Wake, D.J., Seckl, J.R. and Walker, B.R. 2003. Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol/cortisone metabolite ratios in men with fatty liver. J. Clin. Endocrinol. Metab. 88: 4924-4931.
37. Wilber, A., Lu, M. and Schneider, M.C. 2002. Deoxyribonuclease I-like III is an inducible macrophage barrier to liposomal transfection. Mol. Ther. 6: 35-42.
38. Yang, Y.H., Dudoit, S., Luu, P., Lin, D.M., Peng, V., Ngai, J. and Speed, T.P. 2002. Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation. Nucleic Acids Res. 30: e15.